Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 410

1.

Establishment of a normal hematopoietic and leukemia stem cell hierarchy.

Chao MP, Seita J, Weissman IL.

Cold Spring Harb Symp Quant Biol. 2008;73:439-49. doi: 10.1101/sqb.2008.73.031. Review.

PMID:
19022770
2.

Mechanisms of cell commitment in myeloid cell differentiation.

Bedi A, Sharkis SJ.

Curr Opin Hematol. 1995 Jan;2(1):12-21. Review.

PMID:
9371967
3.

Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?

Rizo A, Vellenga E, de Haan G, Schuringa JJ.

Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R210-9. Review.

PMID:
16987886
4.

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Amaral S, Curley D, Williams IR, Akashi K, Gilliland DG.

Cancer Cell. 2004 Dec;6(6):587-96.

5.
6.

Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors.

Akala OO, Park IK, Qian D, Pihalja M, Becker MW, Clarke MF.

Nature. 2008 May 8;453(7192):228-32. doi: 10.1038/nature06869.

7.

Lineage development of hematopoietic stem and progenitor cells.

Giebel B, Punzel M.

Biol Chem. 2008 Jul;389(7):813-24. doi: 10.1515/BC.2008.092. Review.

PMID:
18627318
8.

Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.

Kato Y, Iwama A, Tadokoro Y, Shimoda K, Minoguchi M, Akira S, Tanaka M, Miyajima A, Kitamura T, Nakauchi H.

J Exp Med. 2005 Jul 4;202(1):169-79.

9.

Biology of normal and acute myeloid leukemia stem cells.

Dick JE, Lapidot T.

Int J Hematol. 2005 Dec;82(5):389-96. Review.

PMID:
16533740
10.

Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.

Templin C, Kotlarz D, Rathinam C, Rudolph C, Schätzlein S, Ramireddy K, Rudolph KL, Schlegelberger B, Klein C, Drexler H.

Exp Hematol. 2008 Feb;36(2):204-15. doi: 10.1016/j.exphem.2007.10.005.

PMID:
18206728
11.

The molecular control of blood cell development.

Sachs L.

Science. 1987 Dec 4;238(4832):1374-9. Review.

PMID:
3317831
14.

Stem cell origin of cancer and differentiation therapy.

Sell S.

Crit Rev Oncol Hematol. 2004 Jul;51(1):1-28. Review.

PMID:
15207251
15.

[The hematopoietic stem cell and the stromal microenvironment].

Charbord P.

Therapie. 2001 Jul-Aug;56(4):383-4. Review. French.

PMID:
11677858
16.

Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.

Tsiftsoglou AS, Bonovolias ID, Tsiftsoglou SA.

Pharmacol Ther. 2009 Jun;122(3):264-80. doi: 10.1016/j.pharmthera.2009.03.001. Review.

PMID:
19306896
17.

Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.

Kikushige Y, Yoshimoto G, Miyamoto T, Iino T, Mori Y, Iwasaki H, Niiro H, Takenaka K, Nagafuji K, Harada M, Ishikawa F, Akashi K.

J Immunol. 2008 Jun 1;180(11):7358-67.

18.

Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires rac-mediated interaction with stromal cells.

Rozenveld-Geugien M, Baas IO, van Gosliga D, Vellenga E, Schuringa JJ.

Exp Hematol. 2007 May;35(5):782-92.

PMID:
17577927
19.

Origin of cancer stem cells: the role of self-renewal and differentiation.

Wu XZ.

Ann Surg Oncol. 2008 Feb;15(2):407-14. Review.

PMID:
18043974
20.

Leukemic stem cells: where do they come from?

Passegué E, Weisman IL.

Stem Cell Rev. 2005;1(3):181-8. Review.

PMID:
17142854
Items per page

Supplemental Content

Support Center